Technical Data
Angiotensin Converting Enzyme 2 (ACE-2, ACEH) Ectodomain
Angiogensin I Converting Enzyme-2 (ACE-2) is a type I transmembrane zinc protease that
cleaves angiotensins I and II to produce vasodilatory and anti-proliferative peptides. The
balance between ACE-1 and ACE-2 activity is critical for maintaining cardiovascular, renal,
and pulmonary function. ACE-2 isoforms of 75kD and 120kD are differentially expressed
between lung and kidney, respectively, and a shed soluble form is generated by
TACE/ADAM17 mediated cleavage. ACE-2 also functions as the cellular uptake receptor for
the SARS coronoavirus. Within the extracellular domain, human ACE-2 shares 83% aa
sequence identity with mouse and rat ACE-2.

Suitable for use in ELISA, Western Blot, Immunohistochemistry. Other applications not tested.

Recommended Dilution:
ELISA: 0.5-1.0ug/ml
Western Blot: 2ug/ml
Immunohistochemistry: 25ug/ml
Optimal dilutions to be determined by the researcher.

Mouse myeloma with B cells obtained from a mouse.

Storage and Stability:
Lyophilized powder may be stored at 4C for short-term only. Reconstitute to nominal volume by adding sterile 40-50% glycerol and store at -20C. Reconstituted product is stable for 12 months at -20C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
MabIgG2a9H63Affinity Purified
500ug-20CBlue IceHumanMouse
NS0-derived recombinant human ACE-2 aa18-740; Q9BYF1.
Purified by Protein G affinity chromatography.
Supplied as a lyophilized powder in 0.2um sterile-filtered solution in PBS with 5% trehalose. Reconstitute with 40-50% glycerol, PBS.
Recognizes human ACE-2 ectodomain.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.